Loading
Brazilian surgeon who first showed that rectal cancers that vanish after chemoradiation can be watched rather than removed.
Angelita Habr-Gama (University of São Paulo) published the 2004 series demonstrating that patients with a clinical complete response to chemoradiation for distal rectal cancer could safely avoid surgery, founding the watch-and-wait approach now tested in OPRA and adopted worldwide. She has led the International Watch & Wait Database and continues to refine response assessment and salvage strategies.
Shares Randomise organ preservation against surgery in mismatch repair-proficient rectal cancer, with bowel function as a co-primary endpoint, Rectal cancer, Colorectal cancer and the tags colorectal, surgery, organ-preservation.
Shares Organ preservation (watch-and-wait, bladder-sparing, larynx preservation), Rectal cancer, Colorectal cancer and the tag colorectal.
Shares Colorectal cancer and the tags colorectal, surgery.
Shares Rectal cancer, Colorectal cancer and the tag colorectal.
Shares Organ preservation (watch-and-wait, bladder-sparing, larynx preservation), Chemoradiation (chemoradiotherapy, CRT), Rectal cancer, Colorectal cancer.
Shares Complete response, Organ preservation (watch-and-wait, bladder-sparing, larynx preservation), Randomise organ preservation against surgery in mismatch repair-proficient rectal cancer, with bowel function as a co-primary endpoint, Rectal cancer.
Shares Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results, Organ preservation (watch-and-wait, bladder-sparing, larynx preservation), Randomise organ preservation against surgery in mismatch repair-proficient rectal cancer, with bowel function as a co-primary endpoint, Rectal cancer.
Shares Rectal cancer, Colorectal cancer and the tag colorectal.